Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
High-dose oral N-acetylcysteine versus placebo in ischemic stroke
IRCT20120215009014N215Phase 2Completed
- Sponsor
- Hamadan University of Medical Sciences
- Start
- Apr 2018
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 2 trial of acetylcysteine in ischemic stroke (2 arms), sponsored by Hamadan University of Medical Sciences. Primary endpoints: Serum TNF-alpha level, Serum interleukin-6 level and 2 more. Started Apr 2018; status: completed.
02
Drugs
acetylcysteine
03
Conditions
ischemic stroke
Beyond the preview
Go deeper on IRCT20120215009014N215.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on IRCT20120215009014N215.